J2778 Injection, ranibizumab, 0.1 mg
Billable / valid for submission HCPCS Release 2026Q3
Short description: Ranibizumab injection
Version history
| Release | Valid from | Valid to | Description | Billable |
|---|---|---|---|---|
| 2026Q3 | 2026-07-01 | current | Injection, ranibizumab, 0.1 mg | yes |
Related codes in J27
- J2700 Injection, oxacillin sodium, up to 250 mg
- J2704 Injection, propofol, 10 mg
- J2710 Injection, neostigmine methylsulfate, up to 0.5 mg
- J2711 Injection, neostigmine methylsulfate 0.1 mg and glycopyrrolate 0.02 mg
- J2720 Injection, protamine sulfate, per 10 mg
- J2724 Injection, protein c concentrate, intravenous, human, 10 iu
- J2725 Injection, protirelin, per 250 mcg
- J2730 Injection, pralidoxime chloride, up to 1 gm
- J2760 Injection, phentolamine mesylate, up to 5 mg
- J2765 Injection, metoclopramide hcl, up to 10 mg
- J2770 Injection, quinupristin/dalfopristin, 500 mg (150/350)
- J2777 Injection, faricimab-svoa, 0.1 mg
- J2779 Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg
- J2781 Injection, pegcetacoplan, intravitreal, 1 mg
- J2782 Injection, avacincaptad pegol, 0.1 mg
- J2783 Injection, rasburicase, 0.5 mg
- J2785 Injection, regadenoson, 0.1 mg
- J2786 Injection, reslizumab, 1 mg
- J2787 Riboflavin 5'-phosphate, ophthalmic solution (photrexa viscous/photrexa), up to 3 ml
- J2788 Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.)